Schedule 13G ownership disclosure

Supernus Pharmaceuticals Inc

Security class unavailable · CUSIP: 868459108

Event date: 2014-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,811,388
Percent of class
4.0500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001009012-15-000002
Form type
SC 13G/A
Filer
SUPERNUS PHARMACEUTICALS, INC.
CIK
CIK 1356576
Filed
Jan 22, 2015
Reporting period
Dec 31, 2014
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub